HIGHLIGHTS
SUMMARY
Study finds that in HCC, circulating neutrophils may promote tumor development and can more accurately predict prognosis (Margetts et_al, 2018; Quintela et_al, 2019). Hepatocellular carcinoma (HCC) is the most common case type of liver cancer and the fifth leading cause of cancer-related death worldwide (Ioannou et_al, 2007; Global Burden of Disease Study 2013 Collaborators, 2015; Lersritwimanmaen and Nimanong, 2018). Even if detected early, with surgical resection, the best treatment, recurrence rates are high (Famularo et_al, 2018; Fujiwara et_al, 2018). Among them, the development of anti-tumor immunotherapy is particularly rapid, and it has . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.